SYS-CON MEDIA Authors: Pat Romanski, Gary Arora, Zakia Bouachraoui, Yeshim Deniz, Liz McMillan

News Feed Item

Arthur Frommer Tells America Where to Stop When They Need to Go

New, free U.S. travel guide takes the guesswork out of 'finding the facilities'

EAST HANOVER, N.J., May 27 /PRNewswire/ -- While most Americans look forward to summer travel, anxiety may replace anticipation for the one out of six adults over age 40 with a condition called overactive bladder (OAB). To help people with OAB avoid embarrassment when they head outside their homes, world-renowned travel expert Arthur Frommer has partnered with Novartis Pharmaceuticals Corporation to develop Where to Stop & Where to Go: A Guide to Traveling with Overactive Bladder in the United States.

(Photo: http://www.newscom.com/cgi-bin/prnh/20050527/LAFRU2 )

Available free-of-charge to people across the U.S., the Frommer-authored guide is the centerpiece of a new educational campaign designed to help the more than 33 million people with OAB in the United States build confidence about traveling close to and far from home -- instead of limiting travel because of their condition. The first-of-its-kind 75-page guide highlights key restaurants, museums, and other tourist attractions in 19 U.S. cities and four national parks, providing an easy-to-follow list of restroom locations. To obtain a free copy of Where to Stop & Where to Go, consumers can call toll-free 1-877-STOP-GO-5 (1-877-786-7465) or log onto http://www.wheretostopwheretogo.com/.

"While researching this guide, I experienced firsthand what traveling with overactive bladder is like -- needing to ask strangers about locating a restroom or trying to persuade a salesperson to give me access to their facilities -- all while time is of the essence," said Frommer, the campaign's spokesperson. "It quickly became clear that we could do a lot to alleviate stress and anxiety by getting those questions answered for people with overactive bladder. That is why this campaign is so important."

The campaign website, http://www.wheretostopwheretogo.com/, also provides: * Helpful tips on traveling with OAB, such as "look for a major nationwide retail chain" as many appear to maintain public restrooms as a matter of national policy; * A downloadable "Stop & Go" card -- a wallet-sized "bathroom pass" that offers people with OAB a quick and easy way to explain their need to use the restroom while traveling; * Links to additional information and resources on OAB.

Adults with OAB often limit daily activities, such as travel and shopping, due to symptoms that include urinary urgency (having a strong need to go to the bathroom right away), frequency (having to go to the bathroom too often), and incontinence (sudden/involuntary loss of bladder control). In fact, recent market research shows that travel is second only to sleep among the activities that OAB patients say are impacted by their condition.

In a recent survey of 215 OAB sufferers, more than half of the patients currently being treated for their OAB still experienced symptoms including urinary frequency and wetting accidents.

"With or without treatment, many people with overactive bladder still shape their lives around their need to be near a restroom, which can severely hinder even local trips to museums or shops," said Pamela Ellsworth, MD, chief, Division of Urology in the Department of Surgery, University of Massachusetts Memorial Medical Center. "Our hope is that by combining use of effective medication with tools such as Where to Stop & Where to Go to better manage the condition, patients may be able to enjoy some of the things they may have been missing."

Enablex is indicated for the treatment of OAB with symptoms of urge urinary incontinence, urgency and frequency. Enablex is a potent muscarinic receptor antagonist that helps reduce incontinence episodes, increases the amount of urine that the bladder can hold, and decreases the pressure or urgency associated with the urge to urinate. It offers a unique M3 profile with sustained efficacy and low rates of central nervous system and cardiovascular side effects. Enablex works by blocking the M3 receptor that is primarily responsible for bladder muscle contraction.

Enablex has been studied in 98 clinical trials involving more than 10,500 people. In clinical trials, the most frequently reported adverse events with Enablex were dry mouth, constipation, dyspepsia and abdominal pain; however, patient discontinuation rates due to these events were low. The majority of adverse events in Enablex-treated subjects were mild or moderate and mostly occurred during the first two weeks of treatment. As with other OAB medications, Enablex is contraindicated in patients with urinary retention, gastric retention or uncontrolled narrow-angle glaucoma and in patients who are at risk for these conditions. Enablex is also contraindicated in patients with known hypersensitivity to the drug or its ingredients.

Novartis Pharmaceuticals Corporation researches, develops, manufactures and markets leading innovative prescription drugs used to treat a number of diseases and conditions, including central nervous system disorders, organ transplantation, cardiovascular diseases, dermatological diseases, respiratory disorders, cancer and arthritis. The company's mission is to improve people's lives by pioneering novel healthcare solutions.

Located in East Hanover, New Jersey, Novartis Pharmaceuticals Corporation is an affiliate of Novartis AG -- a world leader in pharmaceuticals and consumer health. In 2004, the Novartis Group's businesses achieved sales of USD 28.2 billion and pro forma net income of USD 5.6 billion. The Group invested approximately USD 4.2 billion in R&D. Headquartered in Basel, Switzerland, Novartis Group companies employ approximately 81,400 people and operate in over 140 countries around the world. For further information please consult http://www.novartis.com/.

Novartis Pharmaceuticals Corporation

CONTACT: Kate O'Connor of Novartis Pharma Communications,
+1-862-778-5588 or +1-917-446-7400, or [email protected]

Web site: http://www.novartis.com/
http://www.wheretostopwheretogo.com/
http://www.enablex.com/

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
DevOps has long focused on reinventing the SDLC (e.g. with CI/CD, ARA, pipeline automation etc.), while reinvention of IT Ops has lagged. However, new approaches like Site Reliability Engineering, Observability, Containerization, Operations Analytics, and ML/AI are driving a resurgence of IT Ops. In this session our expert panel will focus on how these new ideas are [putting the Ops back in DevOps orbringing modern IT Ops to DevOps].
Most modern computer languages embed a lot of metadata in their application. We show how this goldmine of data from a runtime environment like production or staging can be used to increase profits. Adi conceptualized the Crosscode platform after spending over 25 years working for large enterprise companies like HP, Cisco, IBM, UHG and personally experiencing the challenges that prevent companies from quickly making changes to their technology, due to the complexity of their enterprise. An accomp...
Cloud Storage 2.0 has brought many innovations, including the availability of cloud storage services that are less expensive and much faster than previous generations of cloud storage. Cloud Storage 2.0 has also delivered new and faster methods for migrating your premises storage environment to the cloud and the concept of multi-cloud. This session will provide technical details on Cloud Storage 2.0 and the methods used to efficiently migrate from premises-to-cloud storage. This session will als...
At CloudEXPO Silicon Valley, June 24-26, 2019, Digital Transformation (DX) is a major focus with expanded DevOpsSUMMIT and FinTechEXPO programs within the DXWorldEXPO agenda. Successful transformation requires a laser focus on being data-driven and on using all the tools available that enable transformation if they plan to survive over the long term. A total of 88% of Fortune 500 companies from a generation ago are now out of business. Only 12% still survive. Similar percentages are found throug...
Every organization is facing their own Digital Transformation as they attempt to stay ahead of the competition, or worse, just keep up. Each new opportunity, whether embracing machine learning, IoT, or a cloud migration, seems to bring new development, deployment, and management models. The results are more diverse and federated computing models than any time in our history.
Andrew Keys is co-founder of ConsenSys Enterprise. He comes to ConsenSys Enterprise with capital markets, technology and entrepreneurial experience. Previously, he worked for UBS investment bank in equities analysis. Later, he was responsible for the creation and distribution of life settlement products to hedge funds and investment banks. After, he co-founded a revenue cycle management company where he learned about Bitcoin and eventually Ethereum.
At CloudEXPO Silicon Valley, June 24-26, 2019, Digital Transformation (DX) is a major focus with expanded DevOpsSUMMIT and FinTechEXPO programs within the DXWorldEXPO agenda. Successful transformation requires a laser focus on being data-driven and on using all the tools available that enable transformation if they plan to survive over the long term. A total of 88% of Fortune 500 companies from a generation ago are now out of business. Only 12% still survive. Similar percentages are found throug...
CloudEXPO has been the M&A capital for Cloud companies for more than a decade with memorable acquisition news stories which came out of CloudEXPO expo floor. DevOpsSUMMIT New York faculty member Greg Bledsoe shared his views on IBM's Red Hat acquisition live from NASDAQ floor. Acquisition news was announced during CloudEXPO New York which took place November 12-13, 2019 in New York City. Our Silicon Valley 2019 schedule will showcase 200 keynotes, sessions, general sessions, power panels, and...
Bill Schmarzo, author of "Big Data: Understanding How Data Powers Big Business" and "Big Data MBA: Driving Business Strategies with Data Science" is responsible for guiding the technology strategy within Hitachi Vantara for IoT and Analytics. Bill brings a balanced business-technology approach that focuses on business outcomes to drive data, analytics and technology decisions that underpin an organization's digital transformation strategy. Bill has a very impressive background which includes ...
Darktrace is the world's leading AI company for cyber security. Created by mathematicians from the University of Cambridge, Darktrace's Enterprise Immune System is the first non-consumer application of machine learning to work at scale, across all network types, from physical, virtualized, and cloud, through to IoT and industrial control systems. Installed as a self-configuring cyber defense platform, Darktrace continuously learns what is ‘normal' for all devices and users, updating its understa...
While a hybrid cloud can ease that transition, designing and deploy that hybrid cloud still offers challenges for organizations concerned about lack of available cloud skillsets within their organization. Managed service providers offer a unique opportunity to fill those gaps and get organizations of all sizes on a hybrid cloud that meets their comfort level, while delivering enhanced benefits for cost, efficiency, agility, mobility, and elasticity.
Most organizations are awash today in data and IT systems, yet they're still struggling mightily to use these invaluable assets to meet the rising demand for new digital solutions and customer experiences that drive innovation and growth. What's lacking are potent and effective ways to rapidly combine together on-premises IT and the numerous commercial clouds that the average organization has in place today into effective new business solutions. New research shows that delivering on multicloud e...
On-premise or off, you have powerful tools available to maximize the value of your infrastructure and you demand more visibility and operational control. Fortunately, data center management tools keep a vigil on memory contestation, power, thermal consumption, server health, and utilization, allowing better control no matter your cloud's shape. In this session, learn how Intel software tools enable real-time monitoring and precise management to lower operational costs and optimize infrastructure...
Every organization is facing their own Digital Transformation as they attempt to stay ahead of the competition, or worse, just keep up. Each new opportunity, whether embracing machine learning, IoT, or a cloud migration, seems to bring new development, deployment, and management models. The results are more diverse and federated computing models than any time in our history.
Intel is an American multinational corporation and technology company headquartered in Santa Clara, California, in the Silicon Valley. It is the world's second largest and second highest valued semiconductor chip maker based on revenue after being overtaken by Samsung, and is the inventor of the x86 series of microprocessors, the processors found in most personal computers (PCs). Intel supplies processors for computer system manufacturers such as Apple, Lenovo, HP, and Dell. Intel also manufactu...